ethyl 4-((4-(benzo[d]oxazol-2-ylamino)piperidin-1-yl)methyl)-2,6-diethoxybenzoate

ID: ALA1078450

PubChem CID: 46882832

Max Phase: Preclinical

Molecular Formula: C26H33N3O5

Molecular Weight: 467.57

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(OCC)cc(CN2CCC(Nc3nc4ccccc4o3)CC2)cc1OCC

Standard InChI:  InChI=1S/C26H33N3O5/c1-4-31-22-15-18(16-23(32-5-2)24(22)25(30)33-6-3)17-29-13-11-19(12-14-29)27-26-28-20-9-7-8-10-21(20)34-26/h7-10,15-16,19H,4-6,11-14,17H2,1-3H3,(H,27,28)

Standard InChI Key:  OZKJQXVQMICDTB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -4.1722  -17.9794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1735  -18.8070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4559  -19.2198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4579  -17.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7444  -17.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7441  -18.8019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9573  -19.0551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4690  -18.3883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9587  -17.7178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6440  -18.3874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2309  -19.0995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6425  -19.8161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2331  -20.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5923  -20.5297    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0064  -19.8170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5953  -19.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0025  -21.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8274  -21.2461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2349  -21.9635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0590  -21.9664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4746  -21.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0595  -20.5336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2369  -20.5345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4715  -19.8161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2965  -19.8154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7084  -19.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4689  -22.6804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2938  -22.6835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7037  -23.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2996  -21.2514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7108  -21.9692    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7132  -20.5395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5358  -21.9705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9472  -22.6837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
  6  7  1  0
 14 17  1  0
  7  8  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  9  5  1  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
  8 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 10 11  1  0
 22 24  1  0
 11 12  1  0
 24 25  1  0
 25 26  1  0
  2  3  1  0
 20 27  1  0
  3  6  2  0
 27 28  1  0
  1  2  2  0
 28 29  1  0
  5  4  2  0
 21 30  1  0
 11 16  1  0
 30 31  1  0
 12 13  1  0
 30 32  2  0
 13 14  1  0
 31 33  1  0
 14 15  1  0
 33 34  1  0
M  END

Associated Targets(Human)

SSTR5 Tclin Somatostatin receptor 5 (1477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR3 Tclin Somatostatin receptor 3 (1562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.57Molecular Weight (Monoisotopic): 467.2420AlogP: 4.88#Rotatable Bonds: 10
Polar Surface Area: 86.06Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.70CX Basic pKa: 7.21CX LogP: 3.99CX LogD: 3.77
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -1.04

References

1. Martin RE, Mohr P, Maerki HP, Guba W, Kuratli C, Gavelle O, Binggeli A, Bendels S, Alvarez-Sánchez R, Alker A, Polonchuk L, Christ AD..  (2009)  Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,  19  (21): [PMID:19786348] [10.1016/j.bmcl.2009.09.024]

Source